相关实验视频
Updated: Jun 18, 2026

09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
肥胖类别和代谢紧急情况的严重程度:单一中心回顾性五年研究
Iulia Najette Crintea1,2, Alexandru Cristian Cindrea1,2, Teodor Florin Fulga3
1Department of Surgery, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Healthcare (Basel, Switzerland)
|March 28, 2025
概括
肥胖的严重程度显著增加了代谢紧急情况的风险和严重程度,如高血糖症和急性损伤在急诊室. 较高的肥胖类与较差的结果相关,需要针对肥胖患者进行量身定制的风险评估.
科学领域:
- 紧急医疗 紧急医疗
- 代谢障碍 代谢障碍 代谢障碍
- 肥胖问题研究研究
背景情况:
- 肥胖是一个日益严重的全球健康问题.
- 了解它对急性疾病的影响对于紧急护理至关重要.
- 代谢紧急情况在急诊室 (ED) 中带来了重大风险.
研究的目的:
- 研究肥胖严重程度如何影响急性代谢紧急情况的患病率和结果.
- 分析肥胖类与特定代谢并发症之间的关联.
- 在ED环境中,根据肥胖等级对风险进行分层.
主要方法:
- 从2019年1月到2024年3月,对ED中的433名患者进行了回顾性分析.
- 根据BMI对患者进行WHO肥胖等级 (I,II,III类) 的分类.
- 肥胖类别的代谢紧急情况 (高血糖危机,AKI,电解质失衡) 的比较.
主要成果:
- 肥胖患者发生代谢紧急情况的患病率更高 (37.2%与非肥胖患者相比).
- 过高血糖和急性损伤 (AKI) 在肥胖个体中明显更常见.
- 第三类肥胖是代谢紧急情况的独立风险因素 (aOR=3.2).
结论:
- 代谢紧急情况的严重程度随着肥胖程度的增加而升级.
- 针对肥胖的特定风险分层在ED中至关重要.
- 建议对高风险肥胖患者优先进行代谢监测和早期干预.
相关概念视频
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...

